Stocks
Vaxart Targets H1 2027 for Phase IIb COVID-19 Data, Backed by BARDA
Vaxart (VXRT) announced plans to release top-line data from its Phase IIb COVID-19 trial in the first half of 2027, supported by...
#vaxart 2 articles
Stocks
Vaxart Sets Early 2027 Efficacy Readout, Q2 Sentinel Data Release Imminent
Vaxart (VXRT) anticipates a primary efficacy readout for its oral vaccine platform in early 2027, with a Q2 sentinel data release expected...